Journal Information
Vol. 47. Issue 1.
Pages 35-40 (January 2011)
Download PDF
More article options
Vol. 47. Issue 1.
Pages 35-40 (January 2011)
Full text access
P4 Medicine: the Future Around the Corner
Isoenzimas de lactatodeshidrogenasa en el músculo esquelético de pacientes con EPOC
Patricia Sobradilloa,b,c,
Corresponding author

Corresponding author.
, Francisco Pozoa,d, Álvar Agustía,b,c,e
a Ciber en Enfermedades Respiratorias (CIBERES), Barcelona, Spain
b Instituto del Tórax, Hospital Clínic, Universidad de Barcelona, Spain
c Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
d Hospital 12 de Octubre, Madrid, Spain
e Fundación Caubet Cimera, Mallorca, Spain
This item has received
Article information
Download PDF

Traditional medical practice has always been “reactive”, meaning that the doctor intervenes when there is disease. Theoretical (scale-free networks and complex systems), technological (highly efficient “omic” technologies) and conceptual (systems biology) advances of the last decade prelude the transition towards “anticipatory” medicine centered on health and not disease. This review establishes the fundamental conceptual bases and discusses the principal aspects of this new medicine, known as “P4 Medicine” as it is personalized, predictive, preventive and participatory.

Systems biology
Scale-free networks
Systems biology

La práctica médica tradicional ha sido “reactiva” (el médico interviene cuando hay enfermedad). Los avances teóricos (redes libres de escala y sistemas complejos), tecnológicos (tecnologías “ómicas” de alta eficiencia) y conceptuales (biología de sistemas) habidos en la última década permiten anticipar la transición hacia una medicina “anticipatoria”, centrada en la salud (no en la enfermedad). Esta revisión establece las bases conceptuales fundamentales y discute los principales aspectos de esta nueva medicina, denominada “Medicina P4” por ser personalizada, predictiva, preventiva y participatoria.

Palabras clave:
Biología de sistemas
Redes libres de escala
Sistemas complejo
Full text is only aviable in PDF
J.C. Venter, M.D. Adams, E.W. Myers, P.W. Li, R.J. Mural, G.G. Sutton, et al.
The sequence of the human genome.
Science, 291 (2001), pp. 1304-1351
L.H. Hartwell, J.J. Hopfield, S. Leibler, A.W. Murray.
From molecular to modular cell biology.
Nature, 402 (1999), pp. C47-C52
A.L. Barabasi, Z.N. Oltvai.
Network biology: understanding the cell’s functional organization.
Nat Rev Genet, 5 (2004), pp. 101-113
L. Hood, L. Rowen, D.J. Galas, J.D. Aitchison.
Systems biology at the Institute for Systems Biology.
Brief Funct Genomic Proteomic, 7 (2008), pp. 239-248
B. Bollobás.
Graph. Theory: an Introductory Course.
Springer Verlag, (1979),
R. Albert, A.L. Barabasi.
Statistical mechanics of complex networks.
Rev Mod Phys, 74 (2002), pp. 47-97
Barabasi AL. Linked: How Everything Is Connected to Everything Else and What it Means for Business, Science, and Everyday Life. Perseus Books, 2002.
R. Pastor-Satorras, A. Vespignani.
Epidemic spreading in scale-free networks.
Phys Rev Lett, 86 (2001), pp. 3200-3203
S. Eubank, H. Guclu, V.S. Kumar, M.V. Marathe, A. Srinivasan, Z. Toroczkai, et al.
Modelling disease outbreaks in realistic urban social networks.
Nature, 429 (2004), pp. 180-184
R. Pastor-Satorras, A. Vespignani.
Immunization of complex networks.
Phys Rev E Stat Nonlin Soft Matter Phys, 65 (2002),
Z. Dezso, A.L. Barabasi.
Halting viruses in scale-free networks.
Phys Rev E Stat Nonlin Soft Matter Phys, 65 (2002),
A. Ergun, C.A. Lawrence, M.A. Kohanski, T.A. Brennan, J.J. Collins.
A network biology approach to prostate cancer.
Mol Syst Biol, 3 (2007), pp. 82
X. Lu, V.V. Jain, P.W. Finn, D.L. Perkins.
Hubs in biological interaction networks exhibit low changes in expression in experimental asthma.
Mol Syst Biol, 3 (2007), pp. 98
N.E. Alexis, J.C. Lay, M. Almond, D.B. Peden.
Inhalation of low-dose endotoxin favors local T(H)2 response and primes airway phagocytes in vivo.
J Allergy Clin Immunol, 114 (2004), pp. 1325-1331
N.A. Christakis, J.H. Fowler.
The spread of obesity in a large social network over 32 years.
N Engl J Med, 357 (2007), pp. 370-379
N.A. Christakis, J.H. Fowler.
The collective dynamics of smoking in a large social network.
N Engl J Med, 358 (2008), pp. 2249-2258
A.L. Barabasi.
Network medicine–from obesity to the “diseasome”.
N Engl J Med, 357 (2007), pp. 404-407
J. Lim, T. Hao, C. Shaw, A.J. Patel, G. Szabo, J.F. Rual, et al.
A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.
K.I. Goh, M.E. Cusick, D. Valle, B. Childs, M. Vidal, A.L. Barabasi.
The human disease network.
Proc Natl Acad Sci U S A, 104 (2007), pp. 8685-8690
J. Loscalzo, I. Kohane, A.L. Barabasi.
Human disease classification in the postgenomic era: a complex systems approach to human pathobiology.
Mol Syst Biol, 3 (2007), pp. 124
N.M. Morel, J.M. Holland, J. Van der Greef, E.W. Marple, C. Clish, J. Loscalzo, et al.
Primer on medical genomics. Part XIV: Introduction to systems biology?a new approach to understanding disease and treatment.
Mayo Clin Proc, 79 (2004), pp. 651-658
J.K. Nicholson.
Global systems biology, personalized medicine and molecular epidemiology.
Mol Syst Biol, 2 (2006), pp. 52
H. Kitano.
A robustness-based approach to systems-oriented drug design.
Nat Rev Drug Discov, 6 (2007), pp. 202-210
C.A. Hidalgo, N. Blumm, A.L. Barabasi, N.A. Christakis.
A dynamic network approach for the study of human phenotypes.
D.J. Galas, L. Hood.
Systems Biology and Emerging Technologies Will Catalyze the Transition from Reactive Medicine to Predictive, Personalized. Preventive and Participatory (P4) Medicine.
IBC, 1 (2009), pp. 1-4
M.K. Han, A. Agusti, P.M. Calverley, B.R. Celli, G. Criner, J.L. Curtis, et al.
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD.
Am J Respir Crit Care Med, 182 (2010), pp. 598-604
Copyright © 2011. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options

Are you a health professional able to prescribe or dispense drugs?